Neurotrophins Market - Global Industry Analysis & Forecast US$ Million, 2019 – 2025
Neurotrophins Market - Global Industry Analysis & Forecast US$ Million, 2019 – 2025
The research report on ‘Neurotrophins Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global neurotrophins market generated a revenue of USD XX.X million in 2020 and is expected to reach USD XX.X million by 2025 with a CAGR of XX.X % in the forecast period. The reports contain factors that are currently driving and limiting the growth of the neurotrophins market, with key factors that influence the future of the market. The global economy was affected by COVID-19. It has a significant economic impact on several sectors. The world economy is projected to enter a recession due to losses of trillions of dollars. As lockdowns are increasingly imposed and extended, the economic activities are declining and are affecting the global economy. A chapter on the global neurotrophins market explains the impact of the COVID 19 study. The report helps many vendors in taking the right investment and market development decisions. The report focuses on the global neurotrophins market scenario and its adoption across industry verticals in terms of different use cases.
This report includes the following objectives:
• The market highlights of neurotrophins and the major regions and countries involved in these developments, understand the opportunities and the drive for innovation.
• Study of the different segments of neurotrophins and the overall business trends.
• Identifying segments with enormous growth opportunities and recognizing future demand for the market.
• To analyze the major trends in the different segments that affect and influence the neurotrophins market.
• To analyze the specific regional trends in the neurotrophins market.
• Understand the leading players in the industry and the competitive scenarios for market leaders.
• Analyzing the growth strategies of leading players in the neurotrophins market.
This report includes a detailed analysis of the global neurotrophins market. The report offers estimated market data for the forecast period between 2021 and 2025, focused on 2020 as the base year. Market values were determined based on the total sales of the vendors. The study concerns the demand for neurotrophins in different geographical regions (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America). It also focuses on the trends and problems of the major customer and vendors. The primary and secondary sources were used to produce this analysis. The primary sources include business experts from the main and relevant market. Both primary sources were interviewed to compile and verify relevant qualitative and quantitative information and to identify opportunities. A selection of secondary sources is directories, white papers, blogs, and indexes. A top-down approach has been used to estimate and check the size of the neurotrophins market. The key market players were identified through secondary research in formulating the industry value chain, and the players’ market revenues were determined through primary and secondary research. This included an analytical analysis of the annual reports of key business players and comprehensive interviews with CEOs, directors, vice presidents, and communications managers. Predictions for the regional sector were determined using secondary sources and verified through primary sources. Their cornerstone was the participation of large corporations, sales partners, and distribution networks. Research also included a description of the scale of the research activity of each region. The aggregate value of the market is based on the sales and shares of the companies in the neurotrophins market. Based on the overall market size, the market dimensions of the product segments are determined using the top-down approach.
1. Introduction
2. Market Overview
2.1. Global Neurotrophins Market Introduction
2.2. Macro- Economic Factor
2.3. Market Determinants
2.3.1. Market Driver
2.3.2. Market Restraints
2.3.3. Market Opportunities
2.3.4. Market Challenges
2.4. Technology/Product Roadmap
2.5. PEST Analysis
2.6. Market Growth Opportunity Analysis
3. Market Segmentation
3.1. Global Neurotrophins Market Analysis (US$ Mn), By Product type, 2019 - 2025
3.1.1. Nerve Growth Factor
3.1.2. Brain-Derived Neurotrophic Factor
3.1.3. Dehydroepiandrosterone Sulfate
3.1.4. Other
3.2. Global Neurotrophins Market Analysis (US$ Mn), By Application, 2019 – 2025
3.2.1. Alzheimer’S Disease
3.2.2. Amyotrophic Lateral Sclerosis
3.2.3. Parkinson’S Disease
3.2.4. Others
4. Regional Analysis
4.1. North America Neurotrophins Market Analysis (US$ Mn), 2019 - 2025
4.1.1. By Country
4.1.1.1. U.S.
4.1.1.2. Canada
4.1.2. By Product type
4.1.2.1. Nerve Growth Factor
4.1.2.2. Brain-Derived Neurotrophic Factor
4.1.2.3. Dehydroepiandrosterone Sulfate
4.1.2.4. Other
4.1.3. By Application
4.1.3.1. Alzheimer’S Disease
4.1.3.2. Amyotrophic Lateral Sclerosis
4.1.3.3. Parkinson’S Disease
4.1.3.4. Others
4.2. Europe Neurotrophins Market Analysis (US$ Mn), 2019 - 2025
4.2.1. By Country
4.2.1.1. Germany
4.2.1.2. U.K.
4.2.1.3. France
4.2.1.4. Italy
4.2.1.5. Spain
4.2.1.6. Rest of Europe
4.2.2. By Product type
4.2.2.1. Nerve Growth Factor
4.2.2.2. Brain-Derived Neurotrophic Factor
4.2.2.3. Dehydroepiandrosterone Sulfate
4.2.2.4. Other
4.2.3. By Application
4.2.3.1. Alzheimer’S Disease
4.2.3.2. Amyotrophic Lateral Sclerosis
4.2.3.3. Parkinson’S Disease
4.2.3.4. Others
4.3. Asia Pacific Neurotrophins Market Analysis (US$ Mn), 2019 - 2025
4.3.1. By Country
4.3.1.1. China
4.3.1.2. Japan
4.3.1.3. India
4.3.1.4. Rest of Asia Pacific
4.3.2. By Product type
4.3.2.1. Nerve Growth Factor
4.3.2.2. Brain-Derived Neurotrophic Factor
4.3.2.3. Dehydroepiandrosterone Sulfate
4.3.2.4. Other
4.3.3. By Application
4.3.3.1. Alzheimer’S Disease
4.3.3.2. Amyotrophic Lateral Sclerosis
4.3.3.3. Parkinson’S Disease
4.3.3.4. Others
4.4. Middle East & Africa Neurotrophins Market Analysis (US$ Mn), 2019 - 2025
4.4.1. By Region
4.4.1.1. GCC
4.4.1.2. South Africa
4.4.1.3. Rest of Middle East and Africa
4.4.2. By Product type
4.4.2.1. Nerve Growth Factor
4.4.2.2. Brain-Derived Neurotrophic Factor
4.4.2.3. Dehydroepiandrosterone Sulfate
4.4.2.4. Other
4.4.3. By Application
4.4.3.1. Alzheimer’S Disease
4.4.3.2. Amyotrophic Lateral Sclerosis
4.4.3.3. Parkinson’S Disease
4.4.3.4. Others
4.5. Latin America Neurotrophins Market Analysis (US$ Mn), 2019 - 2025
4.5.1. By Country, 2019 – 2025
4.5.1.1. Brazil
4.5.1.2. Mexico
4.5.1.3. Rest of Latin America
4.5.2. By Product type
4.5.2.1. Nerve Growth Factor
4.5.2.2. Brain-Derived Neurotrophic Factor
4.5.2.3. Dehydroepiandrosterone Sulfate
4.5.2.4. Other
4.5.3. By Application
4.5.3.1. Alzheimer’S Disease
4.5.3.2. Amyotrophic Lateral Sclerosis
4.5.3.3. Parkinson’S Disease
4.5.3.4. Others
5. Competitive Analysis
6. Company Profiles
6.1. Johnson＆Johnson
6.2. Lonza Groups
6.3. FibroGen
6.4. Scil Proteins GmbH
6.5. Merck Serono
6.6. Scil Proteins GmbH
6.7. PeproTech
6.8. GE Healthcare
Research Methodology:
Neurotrophins Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|